Reliq Health Technologies Inc
F:MHN2

Watchlist Manager
Reliq Health Technologies Inc Logo
Reliq Health Technologies Inc
F:MHN2
Watchlist
Price: 0.1316 EUR Market Closed
Market Cap: €29m

Wall St Price Targets

MHN2 Price Targets Summary
Reliq Health Technologies Inc

There are no price targets for MHN2.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Reliq Health Technologies Inc Competitors:
Price Targets
TMP
Tompkins Financial Corp
-3% Downside
AEVA
Aeva Technologies Inc
23% Upside

Revenue
Forecast

59% / Year
Past Growth
127% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
59% / Year
Past Growth
127% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 3 years is 127%.

Gross Profit
Forecast

69% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
69% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Reliq Health Technologies Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Reliq Health Technologies Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MHN2's stock price target?
Not Available

MHN2 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Reliq Health Technologies Inc?
Projected CAGR
127%

Over the last 6 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 3 years is 127%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett